Skip to main content
. 2022 Jan 31;115(4):1069–1079. doi: 10.1093/ajcn/nqac020

TABLE 2.

Longitudinal changes in maternal and neonatal iron status1

Trimester 2 (visit 1: 57Fe dose) Trimester 3 (visit 4: 58Fe dose) Delivery Neonate
Gestational age, wk 15.0 ± 0.7 34.0 ± 0.7 39.4 ± 1.8 39.4 ± 1.8
n 15 13 15 15
Weight, kg 68.9 ± 21.2a 77.7 ± 18.8b 79.9 ± 20.7c 3.4 ± 0.3
Hemoglobin, g/dL 12.2 ± 1.9 11.0 ± 1.3 11.6 ± 1.2 13.7 ± 2.3
Anemia, % 7a 54b 23a 33
Serum ferritin, ug/L 50.1 [30.6, 82.2]a 22.7 [12.1, 42.8]b 33.8 [17.6, 64.6]c 205.8 [141.5, 299.3]
Serum ferritin <12 ug/L, % 7 25 8
Transferrin receptor, mg/L 3.6 [2.6, 5.0]a 4.9 [3.6, 6.6]b 5.3 [3.83, 7.4]c 6.2 ± 1.8
Total body iron, mg/kg 8.0 ± 3.4a 4.0 ± 3.5ab 5.2 ± 4.1b 11.3 ± 3.0
Erythroferrone, ng/mL 0.7 [0.4, 1.5] 0.8 [0.4, 1.7] 0.7 [0.4, 1.3] 1.6 [0.8, 3.3]
Erythropoietin, mIU/mL 18.5 [12.4, 27.7]a 30.4 [17.6, 52.3]b 29.5 [16.3, 53.2]a 27.4 [16.6, 45.0]
Hepcidin, ng/mL 10.8 ± 7.5 5.4 ± 5.1 36.0 ± 18.1
Undetectable hepcidin, % 7 0 0
1

Data are presented as mean ± SD for normally distributed data or geometric mean [95% CI] for nonnormally distributed data. Values with different superscripts within a row significantly differ from one another, P < 0.05. Neonatal iron status was determined using umbilical cord blood. Undetectable hepcidin was classified as values <0.39 ng/mL.